| Schedule of Segment Reporting Information, by Segment |
Summary of segment net loss, including segment expenses were as follows:
| | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | 2025 | | 2024 | | | (in thousands) | | Revenues: | | | | | | Net product revenue | | $ | 1,262 | | | $ | 1,093 | | | | | | | | Royalties and other revenue | | — | | | 37 | | | Total revenues | | 1,262 | | | 1,130 | | | Operating expenses: | | | | | | Cost of sales | | 30 | | | 31 | | | Research and development | | 13,609 | | | 12,777 | | | Sales and marketing | | 2,674 | | | 22,681 | | | General and administrative | | 7,826 | | | 6,635 | | Other segment expense (1) | | 2,802 | | | 4,339 | | | Total operating expenses | | 26,941 | | | 46,463 | | | Loss from operations | | (25,679) | | | (45,333) | | | Interest and other expense | | (1,835) | | | (4,948) | | | Interest income and other, net | | 2,219 | | | 1,884 | | | Net loss | | $ | (25,295) | | | $ | (48,397) | |
(1) For the three months ended March 31, 2025 and 2024, other segment expense primarily includes, among other items, stock compensation of $1.6 million related to research and development personnel for each period; $0.04 million and $0.8 million related to sales and marketing personnel, respectively; and $1.4 million and $1.9 million related to general and administrative personnel.
|